High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort

Tanja Zeller(Universität Hamburg), Stefan Blankenberg(Universität Hamburg), Olli Saarela(University of Toronto), Maria Hughes(Queen's University Belfast), Mark Woodward(UNSW Sydney), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Allan D. Struthers(University of Dundee), Hugh Tunstall‐Pedoe(University of Dundee), Francisco Ojeda(Universidad Complutense de Madrid), Veikko Salomaa(Finnish Institute for Health and Welfare), Renate B. Schnabel(Universität Hamburg), Frank Kee(Queen's University Belfast), Tarja Tuovinen(Finnish Institute for Health and Welfare)
Research Portal (Queen's University Belfast)
March 20, 2014
Cited by 0

Related Papers

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
|The Lancet|2010|4.2k
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
|The Lancet|2021|3.8k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k